Crinetics Pharmaceuticals Inc buy TD Cowen
Start price
11.02.25
/
50%
€33.60
Target price
11.02.26
-
Performance (%)
11.90%
End price
12.02.26
€37.60
Summary
This prediction ended on 12.02.26 with a price of €37.60. The prediction had a final performance of 11.90%. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | -0.164% | -0.164% | 188.189% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by TD_Cowen for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten